“…Moreover, BNP is increased in subjects with early stages of cardiac diseases such as diastolic dysfunction and left ventricular hypertrophy which also are associated with AF [7,8]. In population-based studies, BNP predicted major cardiovascular outcomes in subjects without known cardiac diseases [9,10]. However, data on the ability of BNP to predict future AF based on general population cohorts are limited.…”
Elevated levels of BNP are associated with significant excess of incident AF, independent of traditional AF risk factors in the general population. Gender-specific BNP thresholds may help in prevention by detecting unknown or future AF, which carries a high risk of stroke events.
“…Moreover, BNP is increased in subjects with early stages of cardiac diseases such as diastolic dysfunction and left ventricular hypertrophy which also are associated with AF [7,8]. In population-based studies, BNP predicted major cardiovascular outcomes in subjects without known cardiac diseases [9,10]. However, data on the ability of BNP to predict future AF based on general population cohorts are limited.…”
Elevated levels of BNP are associated with significant excess of incident AF, independent of traditional AF risk factors in the general population. Gender-specific BNP thresholds may help in prevention by detecting unknown or future AF, which carries a high risk of stroke events.
“…Different applications have been assigned to N‐terminal section brain natriuretic peptide (NT‐proBNP) in several studies, and an acceptable diagnostic value in distinguishing ischemic stroke from other subtypes (Hajsadeghi et al, ) also predicts presumable cardioembolic stroke independent of coronary calcification (Kara et al, ; Yang et al, ). Moreover, it is a significant predictor of major adverse cardiovascular events in stable coronary disease, as well as a strong predictor of death and a wide range of cardiovascular events (Linssen et al, ; Mishra et al, ) and some non‐cardiovascular causes (Oluleye et al, ).…”
In this study, we estimated the risk of acute coronary syndrome and stroke associated with several emerging cardiovascular risk factors. This was a case-control study, where an age - and sex-matched acute coronary syndrome group and stroke group were compared with controls. Demographic and clinical data were collected through patient interviews, and blood samples were taken for analysis. In the bivariate analysis, all cardiovascular risk factors analyzed showed as predictors of acute coronary syndrome and stroke, except total cholesterol and smoking. In the multivariate logistic regression model for acute coronary syndrome, hypertension and body mass index, N-terminal section brain natriuretic peptide and pregnancy-associated plasma protein-A were independent predictors. For stroke, the predictors were hypertension, diabetes mellitus, body mass index, and N-terminal section brain natriuretic peptide. Controlling for age, sex, and classical cardiovascular risk factors, N-terminal section brain natriuretic peptide and pregnancy-associated plasma protein-A were independent emerging cardiovascular risk factors for acute coronary syndrome, but pregnancy-associated plasma protein-A was not for stroke. High levels of cardiovascular risk factors in individuals with no episodes of cardiovascular disease requires the implementation of prevention programs, given that at least half of them are modifiable.
“…According to Kara et al, 3 BNP predicted stroke in men but not in women, both in subjects under and over 65 years of age. In another study by Duschek et al, 4 the authors assessed NT-proBNP in both men and women with asymptomatic high-grade carotid stenosis, and concluded that male patients ≥75 years with low levels of NT-proBNP had the same survival rate as younger patients, making them eligible for carotid endarterectomy.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.